Filing Flows › CV Sciences (CVSI) › Q1 2025
CV Sciences (CVSI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
CV Sciences (CVSI) reported revenue of $3.6M for the first quarter 2025 (Q1 2025), -10% from a year earlier and -7% from the quarter before. Operating margin was 0.3%, net loss $109K (3.0% of revenue).
CV Sciences, Q1 2025: revenue $3.6M (-10% year over year), operating margin 0.3%, net loss $109K, operating cash flow −$81K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.6M | -7% | -10% |
| Operating profit | $11K | — | — |
| Net earnings | −$109K | — | — |
| Operating cash flow | −$81K | — | — |
What changed
Revenue was $3.6M in Q1 2025, down 10% year over year and down 7% from the previous quarter.
Gross margin was 46.0%, down 0.3 points from a year earlier. Operating profit was $11K, a 0.3% margin (up 15.8 points year over year). Operating expenses fell 33% while revenue fell 10%. The quarter ended with a net loss of $109K, narrower than the previous quarter's $726K loss. Net interest and other expense of $113K was the main reason.
Operating cash flow was −$81K. Non-cash charges added back $82K of depreciation and amortization and $118K of share-based compensation. Working capital and other items used $172K. Capital expenditures of $40K exceeded it, leaving free cash flow of −$121K.
Questions
What was CV Sciences' revenue in the first quarter 2025?
CV Sciences (CVSI) reported revenue of $3.6M for the first quarter 2025 (Q1 2025), -10% from a year earlier and -7% from the quarter before.
Was CV Sciences profitable in the first quarter 2025?
Operating profit was $11K (0.3% of revenue) and net loss $109K.
Source: CV Sciences 10-Q on SEC EDGAR.